Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Active Shortage

ZADITOR

LABORATOIRES THEA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ZADITOR in Canada?

Yes. ZADITOR 0.25MG has an active shortage reported to Health Canada (last updated August 4, 2026).

Why is ZADITOR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will ZADITOR be available again?

The manufacturer's estimated resolution date is February 1, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusActive Shortage
Same-ingredient products on file1 product
Expected resolution~3 months remaining (estimate)
Affected strength0.25MG
Report last updated2026-08-04
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

JAMP KETOTIFEN OPHTHALMIC

JAMP PHARMA CORPORATION

0.25MG · DIN 02542722

Same strengthSame dosage formSame routeNo current shortage

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02242324

Strength

0.25MG

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

KETOTIFEN

See all KETOTIFEN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

Other Products from LABORATOIRES THEA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.